Low pre-treatment neutrophil-to-lymphocyte ratio predicted a better survival in recurrent/metastatic cervical cancer treated with PD-1/PD-L1 inhibitors

Abstract Background A precise predictor is urgently needed for immunotherapy in cervical cancer (CC), which would be very helpful for disease monitoring. Thus, we explore the relationship between pre-treatment neutrophil-to-lymphocyte ratio (NLR) and prognosis in recurrent/metastatic CC patients who...

Descrición completa

Detalles Bibliográficos

Principais autores:	Jing Li, Yulu Wang, Jiayu Pei, Min Wang, Dian Wang, Ruixia Guo, Haifeng Qiu
Formato:	Artigo
Idioma:	Inglês
Publicado:	Springer 2025-09-01
Series:	Discover Oncology
Assuntos:	Cervical cancer NLR Inflammatory indicators PD-1/PD-L1 inhibitors PD-L1 status
Acceso en liña:	https://doi.org/10.1007/s12672-025-02862-z
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!